Skip to Main Content Menu Search Site

Mouris Saghir, Ph.D.

Healthcare Executive

Mouris Saghir, Ph.D.

Mouris is Vice President and General Manager of Quest’s Cardiovascular, Metabolic & Endocrinology Clinical Franchise, which includes Cleveland HeartLab (CHL) clinical laboratory, Quest Diagnostics cardiovascular national center of excellence. Mouris direct efforts to advance cardiovascular, metabolic and endocrine diagnostic innovations that can help patients identify their cardiovascular and metabolic risks and help prevent heart and metabolic diseases, the leading causes of death in the United States.

Mouris has been at Quest Diagnostics since 2011, prior to his current role he focused his efforts on the business-to-business aspect of partnerships with executives of hospitals and health systems. Previously, Mouris spent more than a decade at Pfizer Pharmaceuticals, serving in positions of increasing responsibility in payer brand marketing, portfolio and decision analysis, worldwide global marketing and U.S. marketing for CV and oncology.

Mouris earned his Ph.D. in Diagnostic Medicine from Northeastern University, a master’s degree in management from the Sloan School of Management at the Massachusetts Institute of Technology, and a bachelor’s degree in Medical Technology from Ashland University in Ohio.

At the Wyss Institute, Mouris is a member of the Wyss Mentor Hive who specializes in generating strategic directions to grow businesses in pharmaceutical and diagnostics companies.

The Wyss Mentor Hive is a mentoring program that invites investors and business professionals with significant early stage translational experience, clinical and regulatory experts in driving therapeutic and device development, and serial entrepreneurs with a track record of success to work closely with Wyss entrepreneur teams on startup formation and technology commercialization. Mentors provide feedback to founders and entrepreneurs, while also demonstrating commitment and leadership in the Wyss innovation community.

Close menu